News

Regeneron’s Lynozyfic Gains Accelerated FDA Approval for Multiple Myeloma
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the most undervalued large cap stocks to buy according to analysts. On ...
Nutrien (NTR) Price Target Raised to $65 at Morgan Stanley
Nutrien Ltd. (NYSE:NTR) is one of the 10 best organic food and farming stocks to buy now. On June 26, Morgan Stanley analyst ...
Bispecifics/Bite Market Anticipates Impressive Growth Trajectory During The Forecast Period (2025-2034) Across 7MM Due To Their Expansion Beyond Oncology Delveinsight
The bispecific antibody and BiTE market is witnessing robust growth driven by advances in immuno-oncology and rising demand for targeted canc ...